Ocuphire Pharma, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) €34.01M +51.2% -€29.08M -14.3% -85.5% +0.65 pp N/A N/A
    (estimated) €22.49M +31.5% -€33.93M -3.1% -150.9% +0.54 pp N/A N/A
    (estimated) €17.10M -9.2% -€35.01M +37.6% -204.7% -0.70 pp N/A N/A
    (estimated) €18.84M +50.6% -€25.44M -7.0% -135.0% +0.84 pp N/A N/A
    (estimated) €12.51M +∞% -€27.35M -44.3% -218.5% -2.2 pp N/A N/A
    €0.00 -100.0% -€49.07M +476.1% N/A -€21.82M +2,200.0% N/A
    €16.25M -52.2% -€8.52M -155.8% -52.4% -0.97 pp -€948.48K -107.8% -5.8% -0.42 pp
    €33.99M +6,665.7% €15.26M -131.6% 44.9% +96 pp €12.21M -174.3% 35.9% +33 pp
    €502.39K +∞% -€48.22M +79.6% -9,598.3% -96 pp -€16.44M +262.1% -3,271.6% -33 pp
    €0.00 +NaN% -€26.85M +319.1% N/A -€4.54M +49.2% N/A
    €0.00 +NaN% -€6.41M -47.7% N/A -€3.04M -81.1% N/A
    €0.00 +NaN% -€12.26M -43.2% N/A -€16.12M +23.2% N/A
    €0.00 +NaN% -€21.57M +171.8% N/A -€13.09M +16.1% N/A
    €0.00 +NaN% -€7.94M -35.3% N/A -€11.27M -23.5% N/A
    €0.00 +NaN% -€12.27M -22.3% N/A -€14.75M +56.6% N/A
    €0.00 +NaN% -€15.80M +95.0% N/A -€9.42M +38.3% N/A
    €0.00 +NaN% -€8.10M +52.6% N/A -€6.81M -48.6% N/A
    €0.00 +NaN% -€5.31M -45.1% N/A -€13.25M -772,367.8% N/A
    €0.00 +NaN% -€9.68M +77.6% N/A €1.72K -100.0% N/A
    €0.00 +NaN% -€5.45M +30.0% N/A -€4.39M -∞% N/A
    €0.00 +NaN% -€4.19M +14.1% N/A €0.00 -100.0% N/A
    €0.00 +NaN% -€3.67M -33.6% N/A -€2.90M -17.8% N/A
    €0.00 -100.0% -€5.53M +2.1% N/A -€3.52M +0.0% N/A
    €162.58K -€5.42M -3,331.2% -€3.52M -2,167.5%

    Notifications